Prognostic factors of lupus myelopathy

Lupus
X LuS Ye

Abstract

Myelopathy is a rare but severe neurological manifestation of systemic lupus erythematosus (SLE) with a high morbidity. The factors that contribute to prognosis are unknown. In this study, 14 patients with lupus myelopathy (LM) from our centre were retrospectively studied. Another 23 patients with other neuropsychiatric SLE (NPSLE) features were enrolled as a comparison group. The morbidity of LM was evaluated by the ASIA Impairment Scale. The clinical and serological characteristics and prognostic factors for LM were investigated. The age, gender, duration of SLE, non-CNS disease activity and autoantibody profile in patients with LM was not different in the NPSLE cohort. A relatively low prevalence of anti-phospholipid antibodies (aPL) in LM sera compared to NPSLE (28.6% vs 52.2%, P = 0.19) was observed. Longitudinal lesion detected by magnetic resonance imaging (MRI) was identified in 33.3% of patients with LM, whereas 50% showed focal speckle-like lesions. The morbidity of LM is 50%. Muscle strength of grade 3 or higher on admission was a strong indicator for a better prognosis (P = 0.006), whereas other parameters including longitudinal lesion, sensory deficit level, disease activity and aPL did not discriminate good from p...Continue Reading

References

Mar 4, 2000·Annals of the Rheumatic Diseases·E TrysbergA Tarkowski
Jan 17, 2002·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·G Scotti, S Gerevini
Feb 11, 2004·The American Journal of the Medical Sciences·Hsiang-Cheng ChenDeh-Ming Chang
Nov 22, 2005·The Journal of Spinal Cord Medicine·Ralph J MarinoUNKNOWN ASIA Neurological Standards Committee 2002
Nov 17, 2006·Annals of the Rheumatic Diseases·Mikiko TokunagaYoshiya Tanaka

❮ Previous
Next ❯

Citations

Mar 3, 2009·Journal of Neurology·S DebetteP Vermersch
Feb 23, 2011·Clinical Rheumatology·Yan YeShuang Ye
Nov 19, 2013·Best Practice & Research. Clinical Rheumatology·César Magro ChecaGerda M Steup-Beekman
May 12, 2010·Nature Reviews. Rheumatology·George K Bertsias, Dimitrios T Boumpas
Sep 16, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C G KatsiariP P Sfikakis
Apr 18, 2014·Annals of the Rheumatic Diseases·Ronald F van VollenhovenMatthias Schneider
Nov 29, 2012·Neurologic Clinics·Shin C BehElliot M Frohman
Mar 12, 2011·La Revue de médecine interne·F PerrinC Agard
Jul 1, 2009·Reumatología clinica·Carlos Abud-MendozaR González-Amaro
Apr 23, 2014·Journal of Magnetic Resonance Imaging : JMRI·Christine GohPramit M Phal
Jun 9, 2016·Revista Brasileira De Reumatologia·Beatriz Lavras CostallatSimone Appenzeller
Oct 29, 2011·Neuroimaging Clinics of North America·Christine GohPatricia M Desmond
Dec 30, 2014·Clinical Neurology and Neurosurgery·Raffaele NardoneGiulio Zuccoli
Nov 26, 2014·Nature Reviews. Nephrology·Tak Mao Chan
Sep 4, 2018·Expert Review of Clinical Immunology·Eric J CampbellRosalind Ramsey-Goldman
Jun 23, 2009·The American Journal of Surgical Pathology·Thong NguyenElizabeth Montgomery
Jan 4, 2018·The Korean Journal of Internal Medicine·Soo Min AhnBin Yoo
Dec 28, 2012·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Kyoko MarutaHidetoshi Fukunaga
Nov 4, 2009·The American Journal of Chinese Medicine·Wen-Zong LuXiao-Lei Yang
Jan 6, 2017·Spinal Cord Series and Cases·Javier Pablo HrybMónica Beatriz Perassolo
Feb 7, 2020·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Edson Hernán ChiganerJavier Pablo Hryb

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.